Gastroenterology
Volume 136, Issue 7 , Pages 2304-2315.e4, June 2009

Disruption of Dicer1 Induces Dysregulated Fetal Gene Expression and Promotes Hepatocarcinogenesis

  • Shigeki Sekine

      Affiliations

    • Pathology Division, National Cancer Center Research Institute, Tokyo, Japan
    • Diabetes Center, Department of Medicine, University of California San Francisco, San Francisco, California
    • Corresponding Author InformationReprint requests Address requests for reprints to: Shigeki Sekine, MD, PhD, Pathology Division, National Cancer Center Research Institute, 5-1-1, Tsukiji, Chuo-ku, Tokyo, Japan. fax: (81) 3-3248-2463
  • ,
  • Reiko Ogawa

      Affiliations

    • Pathology Division, National Cancer Center Research Institute, Tokyo, Japan
  • ,
  • Rie Ito

      Affiliations

    • Pathology Division, National Cancer Center Research Institute, Tokyo, Japan
  • ,
  • Nobuyoshi Hiraoka

      Affiliations

    • Pathology Division, National Cancer Center Research Institute, Tokyo, Japan
  • ,
  • Michael T. McManus

      Affiliations

    • Diabetes Center, Department of Medicine, University of California San Francisco, San Francisco, California
  • ,
  • Yae Kanai

      Affiliations

    • Pathology Division, National Cancer Center Research Institute, Tokyo, Japan
  • ,
  • Matthias Hebrok

      Affiliations

    • Diabetes Center, Department of Medicine, University of California San Francisco, San Francisco, California
    • Corresponding Author InformationMatthias Hebrok, PhD, Diabetes Center, Department of Medicine, University of California San Francisco, 613 Parnassus Avenue, HSW1112, Box 0540, San Francisco, California 94143. fax: (415) 564-5813

Received 9 July 2008; accepted 19 February 2009. published online 09 March 2009.

Background & Aims

Growing evidence suggests that microRNAs coordinate various biological processes in the liver. We describe experiments to address the physiologic roles of these new regulators of gene expression in the liver that are as of yet largely undefined.

Methods

We disrupted Dicer, an enzyme essential for the processing of microRNAs, in hepatocytes using a conditional knockout mouse model to elucidate the consequences of loss of microRNAs.

Results

The conditional knockout mouse livers showed the efficient disruption of Dicer1 at 3 weeks after birth. This resulted in prominent steatosis and the depletion of glycogen storage. Dicer1-deficient liver exhibited increased growth-promoting gene expression and the robust expression of fetal stage–specific genes. The consequence of Dicer elimination included both increased hepatocyte proliferation and overwhelming apoptosis. Over time, Dicer1-expressing wild-type hepatocytes that had escaped Cre-mediated recombination progressively repopulated the entire liver. Unexpectedly, however, two thirds of the mutant mice spontaneously developed hepatocellular carcinomas derived from residual Dicer1-deficient hepatocytes at 1 year of age.

Conclusions

Dicer and microRNAs have critical roles in hepatocyte survival, metabolism, developmental gene regulation, and tumor suppression in the liver. Loss of Dicer primarily impairs hepatocyte survival but can promote hepatocarcinogenesis in cooperation with additional oncogenic stimuli.

Abbreviation used in this paper: PCR, polymerase chain reaction

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 30.00 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.
 

 Conflicts of interest The authors disclose no conflicts.

 Funding Supported by a Grant-in-Aid for the Third Term Comprehensive 10-Year Strategy for Cancer Control and a Grant-in-Aid for Cancer Research from the Ministry of Health, Labor and Welfare of Japan, as well as a program for promotion of Fundamental Studies in Health Sciences of the National Institute of Biomedical Innovation (NiBio), Japan. Work in M.H.'s laboratory was supported by a grant from the National Institutes of Health (CA112537).

PII: S0016-5085(09)00353-9

doi:10.1053/j.gastro.2009.02.067

Gastroenterology
Volume 136, Issue 7 , Pages 2304-2315.e4, June 2009